Ahrar K - Search Results

1

A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.

Msaouel P, Goswami S, Thall PF, Wang X, Yuan Y, Jonasch E, Gao J, Campbell MT, Shah AY, Corn PG, Tam AL, Ahrar K, Rao P, Sircar K, Cohen L, Basu S, Duan F, Jindal S, Zhang Y, Chen H, Yadav SS, Shazer R, Der-Torossian H, Allison JP, Sharma P, Tannir NM. Msaouel P, et al. Among authors: ahrar k. Sci Transl Med. 2022 Apr 20;14(641):eabm6420. doi: 10.1126/scitranslmed.abm6420. Epub 2022 Apr 20. Sci Transl Med. 2022. PMID: 35442707 Clinical Trial.

2

Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine?

Sánchez-Ortiz RF, Tannir N, Ahrar K, Wood CG. Sánchez-Ortiz RF, et al. Among authors: ahrar k. J Urol. 2003 Jul;170(1):178-9. doi: 10.1097/01.ju.0000070823.38336.7b. J Urol. 2003. PMID: 12796677 No abstract available.

3

Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.

Ahrar K, Matin S, Wood CG, Wallace MJ, Gupta S, Madoff DC, Rao S, Tannir NM, Jonasch E, Pisters LL, Rozner MA, Kennamer DL, Hicks ME. Ahrar K, et al. J Vasc Interv Radiol. 2005 May;16(5):679-88. doi: 10.1097/01.RVI.0000153589.10908.5F. J Vasc Interv Radiol. 2005. PMID: 15872323

4

Percutaneous image-guided splenic biopsy in the oncology patient: an audit of 156 consecutive cases.

Tam A, Krishnamurthy S, Pillsbury EP, Ensor JE, Gupta S, Murthy R, Ahrar K, Wallace MJ, Hicks ME, Madoff DC. Tam A, et al. Among authors: ahrar k. J Vasc Interv Radiol. 2008 Jan;19(1):80-7. doi: 10.1016/j.jvir.2007.08.025. J Vasc Interv Radiol. 2008. PMID: 18192471

5

Patterns of intervention for renal lesions in von Hippel-Lindau disease.

Matin SF, Ahrar K, Wood CG, Daniels M, Jonasch E. Matin SF, et al. Among authors: ahrar k. BJU Int. 2008 Sep;102(8):940-5. doi: 10.1111/j.1464-410X.2008.07718.x. Epub 2008 May 15. BJU Int. 2008. PMID: 18485044

6

Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors.

Gupta S, Bedikian AY, Ahrar J, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P. Gupta S, et al. Among authors: ahrar j, ahrar k. Am J Clin Oncol. 2010 Oct;33(5):474-80. doi: 10.1097/COC.0b013e3181b4b065. Am J Clin Oncol. 2010. PMID: 19935383

7

Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma.

Karam JA, Ahrar K, Wood CG, Jonasch E, Vikram R, Romero C, Tannir N, Matin SF. Karam JA, et al. Among authors: ahrar k. J Urol. 2010 Nov;184(5):1882-7. doi: 10.1016/j.juro.2010.06.109. Epub 2010 Sep 17. J Urol. 2010. PMID: 20846689 Free PMC article.

8

Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma.

Ahrar J, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P, Bedikian AY. Ahrar J, et al. Among authors: ahrar k. Cancer Invest. 2011 Jan;29(1):49-55. doi: 10.3109/07357907.2010.535052. Cancer Invest. 2011. PMID: 21166498

9

Palliative interventions for pain in cancer patients.

Tam A, Ahrar K. Tam A, et al. Among authors: ahrar k. Semin Intervent Radiol. 2007 Dec;24(4):419-29. doi: 10.1055/s-2007-992330. Semin Intervent Radiol. 2007. PMID: 21326594 Free PMC article.

10

Ablative therapies in renal cell carcinoma.

Chan AA, Ahrar K, Matin SF. Chan AA, et al. Among authors: ahrar k. Minerva Urol Nefrol. 2011 Sep;63(3):237-50. Minerva Urol Nefrol. 2011. PMID: 21993322 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page